Get Live Data

Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

121314151617181920
Date   Source Headline
15th Jul 20196:19 pmRNSDirector/PDMR Shareholding
15th Jul 20196:18 pmRNSDirector/PDMR Shareholding
15th Jul 20196:16 pmRNSDirector/PDMR Shareholding
15th Jul 201911:42 amRNSDirector/PDMR Shareholding
15th Jul 20197:00 amRNSpositive results in Phase 3 PRIMA study of ZEJULA
12th Jul 20194:35 pmRNSDirector/PDMR Shareholding
12th Jul 20193:55 pmRNSDirector/PDMR Shareholding
10th Jul 20193:48 pmRNSDirector/PDMR Shareholding
10th Jul 20197:00 amRNSViiV switch study shows 2DR as effective as 3DR
1st Jul 201912:08 pmRNSTotal Voting Rights
12th Jun 20195:10 pmRNSDirector/PDMR Shareholding
7th Jun 20197:00 amRNSFDA approval for Nucala self-administration
4th Jun 20198:00 amRNSCHMP positive on GSK's Nucala self-administration
3rd Jun 20192:31 pmRNSTotal Voting Rights
24th May 201910:54 amRNSDirector/PDMR Shareholding
20th May 20191:44 pmRNSDirector/PDMR Shareholding
13th May 20195:44 pmRNSBlock listing Interim Review
13th May 20194:19 pmRNSDirector/PDMR Shareholding
8th May 20196:23 pmRNSResult of AGM & GM
2nd May 20195:07 pmRNSTrelegy Ellipta asthma study met primary endpoint
1st May 20193:11 pmRNSDirector/PDMR Shareholding
1st May 20192:32 pmRNSTotal Voting Rights
1st May 201912:00 pmRNS1st Quarter Results
29th Apr 201912:00 pmRNSViiV submits NDA for HIV monthly 2 drug injectable
26th Apr 20194:16 pmRNSViiV receives CHMP Positive Opinion for Dovato
16th Apr 20195:36 pmRNSDirector/PDMR Shareholding
16th Apr 20195:35 pmRNSDirector/PDMR Shareholding
16th Apr 20195:23 pmRNSDirector/PDMR Shareholding
16th Apr 20195:14 pmRNSDirector/PDMR Shareholding
15th Apr 20192:45 pmRNSDirector/PDMR Shareholding
12th Apr 20194:47 pmRNSDirector/PDMR Shareholding
12th Apr 20194:33 pmRNSDirector/PDMR Shareholding
11th Apr 20195:01 pmRNSDirector/PDMR Shareholding
9th Apr 20197:00 amRNSFDA approves ViiV's two-drug HIV regimen, Dovato
2nd Apr 20191:00 pmRNSPublication of AGM and GM Shareholder Documents
1st Apr 20194:36 pmRNSTotal Voting Rights
28th Mar 20194:15 pmRNSGSK reporting changes - product sales and IFRS 16
25th Mar 20195:02 pmRNSDirector/PDMR Shareholding
21st Mar 20194:00 pmRNSGSK announces further positive data from DREAMM-1
19th Mar 20195:45 pmRNSData from GARNET study evaluating dostarlimab
18th Mar 20197:00 amRNSGSK Annual Report 2018 on Form 20-F
12th Mar 20193:19 pmRNSDirector/PDMR Shareholding
12th Mar 20191:00 pmRNSAnnual Financial Report
11th Mar 20196:24 pmRNSDirector/PDMR Shareholding
8th Mar 20197:00 amRNSViiV positive ph3 data for long acting injectable
5th Mar 20195:20 pmRNSDirector/PDMR Shareholding
1st Mar 201910:10 amRNSTotal Voting Rights
22nd Feb 20195:30 pmRNSDirector/PDMR Shareholding
22nd Feb 201911:21 amRNSGSK response to SFO Statement
21st Feb 20194:37 pmRNSDirector/PDMR Shareholding
121314151617181920

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.